Merck & Co. Inc. (MRK)
Trading Center
Loading...
Symbols:
MRK Forum Topics
- All Comments on MRK
- General Discussion on MRK
- Merck's Charm Offensive for Gardasil [view article]
- Why I'm Buying Amylin Now [view article]
- Dow Price Targets from Last November [view article]
- Merck’s Gardasil: A Risky and Unnecessary Vaccine [view article]
- The Top Dividend Paying ETFs and Stocks [view article]
- Biotech Day in Review: Hopeful Results from HIV Conference [view article]
- Looking Inside the New Ben Graham ETN Baskets [view article]
- Time to Invest in Pharmaceuticals? [view article]
- How Have 'Traditional Defensive Stocks' Done in This Downturn? [view article]
- 5 Potential Buyout Targets in Biotech - Barron's [view article]
- Dow 30 Trading Ranges [view article]
- HPC Vaccine Inspires Yellow Health Journalism [view article]
Recent MRK Articles
- Merck's Charm Offensive for Gardasil
- Dow Price Targets from Last November
- Merck’s Gardasil: A Risky and Unnecessary Vaccine
- Why I'm Buying Amylin Now
- Looking Inside the New Ben Graham ETN Baskets
- Time to Invest in Pharmaceuticals?
- 5 Potential Buyout Targets in Biotech - Barron's
- How Have 'Traditional Defensive Stocks' Done in This Downturn?
- Dow 30 Trading Ranges
- $120 Oil's Struggle with the Dow Industrials
- Full List of Articles »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
loading ...
A Bullish Prognosis for Global Healthcare ETFs [view article]
ETFs have their place. I prefer to buy PFE and JNJ direct thru the transfer agents. No fees! ReplyA Bullish Prognosis for Global Healthcare ETFs [view article]
Looks like HQL would appeal to investors looking for higher risk/reward investments in the healthcare sector. Has about 60% invested in biopharma, med devices & diagnostics. Of the top holdings Biomarin (BMRN) has done very well while Acadia Pharma (ACAD) is the worst performer. The fund trades at 15% discount to its NAV with a 9.4% distribution rate. See the full profile at www.etfconnect.com/sel... ReplyA Bullish Prognosis for Global Healthcare ETFs [view article]
I think the long-overdue rotation into healthcare is starting to occur and would favor RXL going forward. The top holdings are JNJ (11%), PFE (8%), MRK (5%), and ABT (4.7%) which should fare well with above-average dividend yields and products that people use regardless of the overall economy. JNJ is actually close to its 52-week high while ABT is mid-range and MRK/PFE are close to their lows. The more it appears a prolonged recession is likely; the better these stocks and RXL should perform. ReplyDaniel
A Bullish Prognosis for Global Healthcare ETFs [view article]
Could you comment, or look into ProShares (RXL. RXL moves 200% relative to the health care basket of stocks. The inverse or short position version is (RXD). RE: RXD if the health sector goes down, then RXD will go up by about 200% I have been using them both depending which way is the momentum of health care looks. I have done better with the short RXD than going long on RXLGaylord Daniel Reply
A Bullish Prognosis for Global Healthcare ETFs [view article]
Have you looked at HQL? ReplyDow 30 Earnings Reports [view article]
Could not agree more. Too small sample size to be statistically representative. ReplyBig Pharma Stocks: Real Rally or Just a One Day Wonder? [view article]
Hi Mike, good article. I'm optimistic about drug stocks. I'm long PFE and have been feeling quite a bit of pain, but I think all of the bad news is cooked into most pharmaceutical stocks. I'm willing to keep adding to my position on dips and collect the nice dividend until the sector resuscitates. ReplyBiotech is Healthy - Fast Money Recap (7/8/08) [view article]
Cramer like Providence Energy Trust...one of the partner of Founder Energy that got bought out by PVX is Gary Schellenberg, now CEO of TNR Gold
Thing will FLY soon.
TNR.v on TSX up 30% since last month Reply
Dow 30 Earnings Reports [view article]
really. one should have the statistic for at least 4 weeks. ReplyDow 30 Earnings Reports [view article]
This is about the most useless article I've seen yet! ReplyDow 30 Price Targets - Too Much Optimism? [view article]
blair is a clever comment - acting on it needs nerves ReplyDow 30 Price Targets - Too Much Optimism? [view article]
My put is that the Dow average is going down to the 2002-03 bear market level, say 7500.Which stocks are going to be the principal 'droppers' that will cause the above forecast to come true implies those stocks that have not been hit too hard so far.
If the above assumption is correct, the financial stocks will bottom out price wise in the recent levels. Reply
UBS: Guarded Outlook for Merck's Gardasil [view article]
The concern about Gardasil should go well beyond adverse event reporting, which every vaccine endures. Many experts are now beginning to say girls should delay vaccination, perhaps till they are 18 or 21. See this link:www.findingdulcinea.co... Reply
Dow 30 Price Targets - Too Much Optimism? [view article]
Only 3 of the 30 showed marginal gain YTD....and that was last week. Brutal year so far. ReplyDow 30 Price Targets - Too Much Optimism? [view article]
I guess it depends on your time line. "C" at a target of $23 over the next 12-15 months is out there, but not unbelievable. The largest gains are made by buying near the bottom. I agree that you should never listen to the sell-side analysts. Reply